SpectRx, Inc. Schedules Date for Release of Third Quarter 2004 Results NORCROSS, Ga., Nov. 4 /PRNewswire-FirstCall/ -- SpectRx, Inc. (OTC:SPRX) (BULLETIN BOARD: SPRX) announced today that it plans to release third quarter 2004 results after the market closes on Wednesday, November 10, 2004. SpectRx will host a conference call and webcast to review the Company's financial results on Thursday, November 11, 2004 at 11:30 a.m. Eastern Time. The webcast will be made available at http://www.fulldisclosure.com/ or http://www.ccbn.com/ . The telephone number to participate in the conference call is 800-889-0817. A replay of the conference call will be made available until November 17, 2004, by dialing 800-642-1687, passcode 2051502. About SpectRx SpectRx, Inc. (OTC:SPRX) (BULLETIN BOARD: SPRX) is a diabetes management company developing and providing innovative solutions for insulin delivery and glucose monitoring. SpectRx markets the SimpleChoice(R) line of innovative diabetes management products, which include insulin pump disposable supplies. SpectRx also plans to develop a consumer device for continuous glucose monitoring. The company is commercializing its non-invasive cancer detection technology through subsidiary company Guided Therapeutics, Inc, which SpectRx intends to separately finance with private funds. For more information, visit SpectRx's web sites at spectrx.com, mysimplechoice.com and guidedtherapeutics.com . DATASOURCE: SpectRx, Inc. CONTACT: Media, Bill Wells, or Financial, Thomas H. Muller, Jr., of SpectRx, Inc., +1-770-242-8723 Web site: http://www.spectrx.com/ http://www.mysimplechoice.com/ http://www.guidedtherapeutics.com/ http://www.fulldisclosure.com/ http://www.ccbn.com/

Copyright